Page 2 - Bio Techne News Today

Allspring Global Investments Holdings LLC lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,309,295 shares of the biotechnology company’s stock after purchasing an additional 170,100 shares during the […]

Fort Washington Investment Advisors Inc. OH increased its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 8.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 238,308 shares of the biotechnology company’s stock after purchasing an additional 19,390 shares […]

Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. The portfolio returned 14.98% gross and 14.65 % net of fees in the fourth quarter compared to a 12.59% return for the Russell 2500 Growth Index. The portfolio returned […]

V Square Quantitative Management LLC raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 246.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,453 shares of the biotechnology company’s stock after acquiring an additional 2,457 shares during the quarter. […]

Victory Capital Management Inc. cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 19.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,360 shares of the biotechnology company’s stock after selling 7,783 shares during the period. […]

Last week, you might have seen that Bio-Techne Corporation ( NASDAQ:TECH ) released its quarterly result to the market...

Dorsey & Whitney Trust CO LLC increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,984 shares of the biotechnology company’s stock after acquiring an additional 1,538 shares during the quarter. […]

Fox Run Management L.L.C. acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,898 shares of the biotechnology company’s stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also […]

Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by equities researchers at Stephens from $92.00 to $87.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Stephens’ target price would indicate a potential upside of 31.72% from the stock’s current […]

Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript February 1, 2024 Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.42. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]